<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jallow F</submitter><funding>U.S. Department of Health &amp;amp; Human Services | Administration for Children &amp;amp; Families | U.S. Children&amp;apos;s Bureau</funding><funding>University of Wisconsin Carbone Cancer Center</funding><funding>NICHD NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | National Institutes of Health</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development</funding><pagination>6913-6925</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6814534</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>38(43)</volume><pubmed_abstract>Metastatic, antiestrogen resistant estrogen receptor α positive (ER+) breast cancer is the leading cause of breast cancer deaths in USA women. While studies have demonstrated the importance of the stromal tumor microenvironment in cancer progression and therapeutic responses, effects on the responses of ER+ cancers to estrogen and antiestrogens are poorly understood, particularly in the complex in vivo environment. In this study, we used an estrogen responsive syngeneic mouse model to interrogate how a COL1A1-enriched fibrotic ECM modulates integrated hormonal responses in cancer progression. We orthotopically transplanted the ER+ TC11 cell line into wild-type (WT) or collagen-dense (Col1a1&lt;sup>tm1Jae/+&lt;/sup>, mCol1a1) syngeneic FVB/N female mice. Once tumors were established, recipients w</pubmed_abstract><journal>Oncogene</journal><pubmed_title>Dynamic interactions between the extracellular matrix and estrogen activity in progression of ER+ breast cancer.</pubmed_title><pmcid>PMC6814534</pmcid><funding_grant_id>R01 CA206458</funding_grant_id><funding_grant_id>P30 Ca014520</funding_grant_id><funding_grant_id>R01 CA179556</funding_grant_id><funding_grant_id>R01 CA157675</funding_grant_id><funding_grant_id>R25 GM083252</funding_grant_id><funding_grant_id>P30 CA014520</funding_grant_id><funding_grant_id>T32 HD041921</funding_grant_id><pubmed_authors>Jallow F</pubmed_authors><pubmed_authors>Schuler LA</pubmed_authors><pubmed_authors>O'Leary KA</pubmed_authors><pubmed_authors>Ponik SM</pubmed_authors><pubmed_authors>Guerrero JF</pubmed_authors><pubmed_authors>Rugowski DE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dynamic interactions between the extracellular matrix and estrogen activity in progression of ER+ breast cancer.</name><description>Metastatic, antiestrogen resistant estrogen receptor α positive (ER+) breast cancer is the leading cause of breast cancer deaths in USA women. While studies have demonstrated the importance of the stromal tumor microenvironment in cancer progression and therapeutic responses, effects on the responses of ER+ cancers to estrogen and antiestrogens are poorly understood, particularly in the complex in vivo environment. In this study, we used an estrogen responsive syngeneic mouse model to interrogate how a COL1A1-enriched fibrotic ECM modulates integrated hormonal responses in cancer progression. We orthotopically transplanted the ER+ TC11 cell line into wild-type (WT) or collagen-dense (Col1a1&lt;sup>tm1Jae/+&lt;/sup>, mCol1a1) syngeneic FVB/N female mice. Once tumors were established, recipients w</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Oct</publication><modification>2025-04-05T13:50:46.871Z</modification><creation>2020-05-22T09:47:32Z</creation></dates><accession>S-EPMC6814534</accession><cross_references><pubmed>31406251</pubmed><doi>10.1038/s41388-019-0941-0</doi></cross_references></HashMap>